Shire Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Shire Pharmaceuticals, Inc.
Quantité totale PI 5
Quantité totale incluant filiales 6 (+ 1 pour les filiales)
Rang # Quantité totale PI 316 792
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 711 010
Parent Shire plc

Brevets

Marques

0 0
0 0
5 0
0
 
Dernier brevet 2019 - Salts of amphetamine-homoarginin...
Premier brevet 2005 - Method of treating hyperphosphat...

Filiales

1 subsidiaries with IP (0 patents, 1 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2019 Invention Salts of amphetamine-homoarginine conjugate prodrug. Disclosed are improved amphetamine-homoargin...
Invention Amphetamine prodrug and crystalline froms thereof. The present invention relates to crystalline f...
2018 Invention Methods of treatment using an amphetamine prodrug. Disclosed are methods of treatment of various ...
2010 Invention Prodrugs of opioids and uses thereof. The present invention concerns prodrugs of opioid analgesi...
2007 Invention Transdermal delivery of meptazinol. A delivery system for the delivery of a salt of meptazinol w...
Invention Transdermal delivery of meptazinol. A delivery system for the delivery of a salt of meptazinol wh...
2006 Invention Transdermal delivery of meptazinol. A delivery system for the delivery of a salt of meptazinol o...
Invention Transdermal delivery of meptazinol. A delivery system for the delivery of a salt of meptazinol or...
2005 Invention Quinazoline derivatives and their use in the treatment of thrombocythemia. A method for the treat...
Invention Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodie...
Invention Method of treating hyperphosphataemia using lanthanum hydroxycarbonate. This disclosure relates ...
Invention Method of treating hyperphosphataemia using lanthanum hydroxycarbonate. This disclosure relates t...